Given Imaging (GIVN) Reports Q3 EPS of $0.20; Raises FY09 EPS Guidance
More News related to GIVN
- Given Imaging (GIVN) Announces the Degree of Impact the PillCam SB has on GI Patients, Crohn's Disease
- Three Studies Find PillCam(R) SB Enables Earlier Diagnosis and Treatment of GI Diseases Including Crohn's
- Given Imaging (GIVN) Announces Viability of PillCam Capsule in Pediatric Patients
- Given Imaging Announces RAPID(R) pH Software for Bravo(R) pH Monitoring System
- New Studies Show PillCam(R) SB to Be Clinically Valuable in Classifying and Managing Pediatric GI Symptoms
More News related to Earnings
- Maxim Group Initiates Coverage on Golden Green Enterprises (CHOP) with a Buy
- Hilliard Lyons Initiates Coveage on Approach Resources (AREX) with a Buy
- Wells Fargo Transfers Coverage on Intuitive Surgical (ISRG) to a Market Perform; Raises Valuation Range
- Wedbush Initiates Coverage on Coinstar (CSTR) with an Outperform
- Thomas Weisel Starts FARO Tech. (FARO) at Overweight, $24 Price Target
Given Imaging Ltd. (NASDAQ: GIVN) reports Q3 EPS of $0.20, versus the analyst estimate of $0.06. Revenue for the quarter was $35.2 million, which compares to the estimate of $35.40 million.
Raises its FY09 EPS guidance to $0.65-$0.67, versus the consensus of $0.32.
Related Categories
EarningsStocks Mentioned
+0.21Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
